Wei Bai
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- RNA modifications and cancer 3
- Peroxisome Proliferator-Activated Receptors 2
- Muscle Physiology and Disorders 2
- RNA Interference and Gene Delivery 2
-
- Advanced Glycation End Products research 4
- Co-authors
- Rama D Natarajan (6 shared papers)Jerry L. Nadler (5 shared papers)Mausumee Guha (1 shared paper)Noe Gonzales (3 shared papers)Alan E. Tomkinson (1 shared paper)Nina Y. Yao (1 shared paper)David S. Levin (1 shared paper)Jing Zhou (7 shared papers)
- Journals
- Hypertension (2 papers)Journal of Cachexia Sarcopenia and Muscle (2 papers)Journal of the American Heart Association (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Bai
37 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 249
- Clinical Biochemistry 93
- Molecular Biology 821
- Biochemistry 80
- Immunology 164
Countries citing papers authored by Wei Bai
This map shows the geographic impact of Wei Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Bai more than expected).
Fields of papers citing papers by Wei Bai
This network shows the impact of papers produced by Wei Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Bai. The network helps show where Wei Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 278 | |
| 2 | 1997 | 206 | |
| 3 | 2005 | 158 | |
| 4 | 1997 | 116 | |
| 5 | 1999 | 89 | |
| 6 | 1997 | 59 | |
| 7 | 1996 | 56 | |
| 8 | 1997 | 56 | |
| 9 | 2018 | 54 | |
| 10 | 2020 | 53 | |
| 11 | 2018 | 44 | |
| 12 | 2015 | 41 | |
| 13 | 2016 | 40 | |
| 14 | 2021 | 39 | |
| 15 | 2019 | 31 | |
| 16 | 2022 | 30 | |
| 17 | 2016 | 24 | |
| 18 | 2019 | 22 | |
| 19 | 2018 | 21 | |
| 20 | 2019 | 21 |
About Wei Bai
Wei Bai is a scholar working on Molecular Biology, Clinical Biochemistry, Biochemistry, Cancer Research and Physiology, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Advanced Glycation End Products research (4 papers), Inflammatory mediators and NSAID effects (3 papers), RNA modifications and cancer (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Muscle Physiology and Disorders (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (249 citations), Clinical Biochemistry (93 citations), Molecular Biology (821 citations), Biochemistry (80 citations) and Immunology (164 citations). Wei Bai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rama D Natarajan, Jerry L. Nadler, Mausumee Guha, Noe Gonzales, Alan E. Tomkinson, Nina Y. Yao, David S. Levin, Jing Zhou, Linda L. Lanting and Jared M. Brown. Their work appears in journals such as Hypertension, Journal of Cachexia Sarcopenia and Muscle, Journal of the American Heart Association, The Journal of Clinical Endocrinology & Metabolism and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.